Photomotor Reflex to Evaluate the Role of the Non-visual Effects of Light in Neurological, Psychiatric and Ophthalmological Pathologies

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Strasbourg, France

About this trial

The light has visual and non-visual effects on organism and can act on the behavior, the mood, the cognition and the sleep. These effects are mediated by "classical" retina photoreceptors which allow vision (rods, cones) but also melanopsin cells. The non-visual effects of light seems to be altered in many neurological, psychiatric or ophtalmological conditions but their exact role in the pathogenesis remains poorly understand. The purpose of the study is to increase our knowledge of the non-visual effects of light and establish new therapeutic applications

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Man or woman

Aged 18 years or older

Subject having signed a free and informed consent

Subject affiliated to a social protection scheme Arm 1 :Subjects with primary sleep-wake disorder Arm 2 : subjects presenting a neurological pathology with disorder of the controls of the wake and the sleep Arm 3 : subject presenting a psychiatric pathology pathology with disorder of the controls of the wake and the sleep Arm 4 : subject presenting an ophthalmological pathology with possible alteration of the photoreception and / or phototransduction Arm 5 : subjects with photosensitivity with regulation disorder of sleep and wake Arm 6 : healthy subject

Disqualifiers

Cataract with significant vision loss <5/10

Chorioretinal neovascularization

Subject in exclusion period determined by previous or current study

Impossibility to give the subject information enlightened (subject in emergency situation, difficulties of understanding the subject, ...)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Specific light exposures

    Other intervention

    Specific light exposures using light in a wide range of intensities or different light/dark regimens

Treatment groups

726 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Group A: primary sleep-wake disorderOther 1 intervention
Group B: neurological pathologyOther 1 intervention
Group C: psychiatric pathologyOther 1 intervention
Group D: ophthalmological pathologyOther 1 intervention
Group E: photosensitivityOther 1 intervention
Group F: group controlOther 1 intervention

Trial outcomes

Primary outcomes

1

PIPR : Post-Illumination Pupil Response

1 measurement per subject is performed after exposure to monochromatic light exposure

Time frame
1 day

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.